Biography and Research Information
OverviewAI-generated summary
James A. Hendrixson's research focuses on the molecular mechanisms regulating bone mass and strength. He has investigated the role of the master autophagy regulator Tfeb in osteoblast lineage cells, finding that its elevation can increase bone mass and strength. His work also explores the efficacy of CRISPR interference compared to the Cre-loxP system for gene editing in specific cell types. Hendrixson has studied the impact of chaperone-mediated autophagy loss on age-related bone loss in male mice, indicating no significant alteration. His collaborations include work with Melda Onal, A. Gordon James, Julie Crawford, and Intawat Nookaew at the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications. Hendrixson's scholarship metrics include an h-index of 3 across 4 total publications with 19 citations.
Metrics
- h-index: 3
- Publications: 4
- Citations: 22
Selected Publications
-
Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength (2025)
-
CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength (2024)
-
Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice (2024)
-
CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system (2023)
-
Retroaortic Left Renal Vein: An Incidental Finding During Cadaver Dissection (2022)
Collaboration Network
Top Collaborators
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
- Loss of chaperone‐mediated autophagy does not alter age‐related bone loss in male mice
- CRISPR interference provides increased cell type-specificity compared to the Cre-loxP system
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- Elevation of master autophagy regulator Tfeb in osteoblast lineage cells increases bone mass and strength
- CRISPR activation of <i>Tfeb</i> , a master regulator of autophagy and lysosomal biogenesis, in osteoblast lineage cells increases bone mass and strength
- Retroaortic Left Renal Vein: An Incidental Finding During Cadaver Dissection
- Retroaortic Left Renal Vein: An Incidental Finding During Cadaver Dissection
- Retroaortic Left Renal Vein: An Incidental Finding During Cadaver Dissection
Similar Researchers
Based on overlapping research topics